Cargando…
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
BACKGROUND: Persons living with human immunodeficiency virus are an underserved population for evidence-based cancer treatment. Paclitaxel and carboplatin (PCb) is an active regimen against a variety of solid tumors, including several seen in excess in patients with HIV infection. We performed a pil...
Autores principales: | Haigentz, Missak, Moore, Page, Bimali, Milan, Cooley, Timothy, Sparano, Joseph, Rudek, Michelle, Ratner, Lee, Henry, David, Ramos, Juan, Deeken, John, Rubinstein, Paul, Chiao, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355812/ https://www.ncbi.nlm.nih.gov/pubmed/35429391 http://dx.doi.org/10.1093/oncolo/oyac004 |
Ejemplares similares
-
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer
por: Takayama, Koichi, et al.
Publicado: (2019) -
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
por: Botello-Harbaum, Maria T, et al.
Publicado: (2012) -
Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075)
por: Ramos, Juan C., et al.
Publicado: (2018) -
AMC: amyoplasia and distal arthrogryposis
por: Kimber, Eva
Publicado: (2015) -
Phase II AIDS Malignancy Consortium (AMC) trial of imatinib in AIDS-associated Kaposi’s sarcoma (KS)
por: Koon, Henry B, et al.
Publicado: (2010)